The trafficking of CARs during activation has been investigated by Li et al. on the CD19-BBζ CAR, and it was shown that engagement of tumor antigens induced rapid ubiquitination of CARs, causing CAR downmodulation followed by lysosomal degradation. Here, CARS1 is linked to neoplasm.